<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04972513</url>
  </required_header>
  <id_info>
    <org_study_id>OSU-20320</org_study_id>
    <secondary_id>NCI-2021-06438</secondary_id>
    <nct_id>NCT04972513</nct_id>
  </id_info>
  <brief_title>Impact of E-cigarette Use on the Body</brief_title>
  <official_title>The Emerging Adulthood Health Project</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University Comprehensive Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University Comprehensive Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study examines how electronic (e)-cigarette use impacts the body, by studying both users&#xD;
      and non-users of e-cigarettes. Early evidence indicates that e-cig users experience adverse&#xD;
      health effects. Results of this study may help policy-makers develop standards for different&#xD;
      types of tobacco.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVE:&#xD;
&#xD;
      Examine the short-term impacts of vaping on pulmonary and respiratory outcomes.&#xD;
&#xD;
      OUTLINE:&#xD;
&#xD;
      Current e-cigarette users will vape their own e-cigarette device ad libitum for 30 minutes;&#xD;
      non-users will watch a neutral video for 30 minutes. Before and after the 30 minute vaping&#xD;
      [video] session, participants will undergo the following assessments: computer-based&#xD;
      spirometry testing, nitric oxide breath testing, airwave oscillometry, and an assessment of&#xD;
      endothelial function. Participants will also undergo collection of blood.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 22, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Airway inflammation as assessed by exhaled nitric oxide</measure>
    <time_frame>Procedure will last approximately 3 minutes; the procedure will occur twice during the laboratory session (separated by approximately 60 minutes)</time_frame>
    <description>Exhaled nitric oxide will be measured in parts per billion (ppb)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Airway reactivity as assessed by airwave oscillometry</measure>
    <time_frame>Procedure will last approximately 3 minutes; the procedure will occur twice during the laboratory session (separated by approximately 60 minutes)</time_frame>
    <description>Airway reactivity will be measured via Tremoflo, which is a well validated measurement of airway reactivity and provides curves of Resistance (R) and Reactance (X)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Respiratory functioning as assessed by a mobile Spirometry device</measure>
    <time_frame>Procedure will last approximately 3 minutes; the procedure will occur twice during the laboratory session (separated by approximately 60 minutes)</time_frame>
    <description>Spirometry will collect daily data from participants on the relationship between their forced expiratory volume and forced vital capacity (measured as FEV1/FVC).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Endothelial function</measure>
    <time_frame>Procedure will last approximately 20 minutes; the procedure will occur twice during the laboratory session (separated by approximately 90 minutes)</time_frame>
    <description>Endothelial function will be assessed with the EndoPAT device (unit of measurement = LnRHI).</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Cigarette Smoking-Related Carcinoma</condition>
  <arm_group>
    <arm_group_label>Prevention (survey, breathe tests, biospecimen collection)</arm_group_label>
    <description>Participants undergo computer-based spirometry testing, nitric oxide breath testing, airwave oscillometry, and an assessment of endothelial function. Participants will undergo collection of blood. Current e-cigarette users also vape their own e-cigarette device for 30 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biospecimen Collection</intervention_name>
    <description>Undergo collection of blood</description>
    <arm_group_label>Prevention (survey, breathe tests, biospecimen collection)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Nitric Oxide Breath Test</intervention_name>
    <description>Undergo nitric oxide breath testing</description>
    <arm_group_label>Prevention (survey, breathe tests, biospecimen collection)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Oscillometry</intervention_name>
    <description>Undergo airwave oscillometry</description>
    <arm_group_label>Prevention (survey, breathe tests, biospecimen collection)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Spirometry</intervention_name>
    <description>Undergo spirometry</description>
    <arm_group_label>Prevention (survey, breathe tests, biospecimen collection)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Survey Administration</intervention_name>
    <description>Complete survey</description>
    <arm_group_label>Prevention (survey, breathe tests, biospecimen collection)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endothelial function</intervention_name>
    <description>Endothelial function will be assessed with the EndoPAT device, which measures changes in pressure from sensors placed on the fingertip</description>
    <arm_group_label>Prevention (survey, breathe tests, biospecimen collection)</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        E-cig (cigarette) users and non-users in Ohio&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  75 e-cig users and 75 never-users&#xD;
&#xD;
          -  No self-reported diagnosis of lung disease (e.g., coronavirus disease-2019 [COVID-19],&#xD;
             pneumonia, cystic fibrosis)&#xD;
&#xD;
          -  No history of cardiac event or distress&#xD;
&#xD;
          -  Not currently breastfeeding, pregnant, or planning to become pregnant (e-cig users&#xD;
             only; will be confirmed via pregnancy test)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>24 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Megan E Roberts, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University Comprehensive Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>The Ohio State University Comprehensive Cancer Center</last_name>
    <phone>800-293-5066</phone>
    <email>OSUCCCClinicaltrials@osumc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ohio State University Comprehensive Cancer Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan E. Roberts, PhD</last_name>
      <phone>614-292-4647</phone>
      <email>roberts.1558@osu.edu</email>
    </contact>
    <investigator>
      <last_name>Megan E. Roberts, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://cancer.osu.edu</url>
    <description>The Jamesline</description>
  </link>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 29, 2021</study_first_submitted>
  <study_first_submitted_qc>July 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 22, 2021</study_first_posted>
  <last_update_submitted>August 19, 2021</last_update_submitted>
  <last_update_submitted_qc>August 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University Comprehensive Cancer Center</investigator_affiliation>
    <investigator_full_name>Megan Roberts</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitric Oxide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

